secwatch.observer — SEC 8-K summary
======================================

Issuer:     Avalon GloboCare Corp. (ALBT)
CIK:        0001630212
Form:       8-K
Filed at:   2023-06-16T23:59:59+00:00
Accession:  0001213900-23-049645
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Avalon GloboCare enters $3.5M ATM offering, reports Lab Services MSO financials
-------------------------------------------------------------------------------

- Entered ATM sales agreement with Roth Capital for up to $3.5M of common stock; 3% commission.
- Owns 40% of Lab Services MSO (Costa Mesa, CA); 2022 revenue $14.7M, net income $6.3M.
- Suspended cellular therapy R&D to focus on laboratory rollup and KetoAir commercialization.
- KetoAir breathalyzer (FDA Class I) detects acetone; exclusive distribution rights in NA, SA, EU, UK.
- Lab Services MSO completed over 600,000 tests since inception; state-of-the-art facility.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1630212/000121390023049645/0001213900-23-049645-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1630212/000121390023049645/ea180444-8k_avalon.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-049645

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer